Smith & Nephew (SNN) Capital Expenditures (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Capital Expenditures of -$172.0 million for Q4 2024, down 2.99% year-on-year from -$177.3 million in Q1 2024, and down 2.99% on a QoQ basis from -$167.0 million in Q4 2023.
Smith & Nephew (SNN) Capital Expenditures (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Capital Expenditures for 16 consecutive years, with -$172.0 million the latest figure, recorded in Q4 2024.
- Quarterly Capital Expenditures fell 2.99% year-over-year to -$172.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$687.0 million (up 2.28% YoY) and the FY2025 annual result came in at $433.0 million, up 13.65% from the prior year.
- Capital Expenditures slipped to -$172.0 million in Q4 2024 per SNN's latest filing, from -$167.0 million in the prior quarter.
- Over the last five years, Capital Expenditures for SNN reached as high as -$167.0 million in Q4 2023 and fell as low as -$188.0 million in Q4 2020.
- A 5-year average of -$175.0 million and a median of -$173.0 million in 2022 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2020 — Capital Expenditures jumped 53.92% — and 2024, when it decreased 2.99%.
- Year by year, Capital Expenditures stood at -$188.0 million in 2020, then climbed by 6.91% to -$175.0 million in 2021, then gained by 1.14% to -$173.0 million in 2022, then rose by 3.47% to -$167.0 million in 2023, then dropped by 2.99% to -$172.0 million in 2024.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$172.0 million, -$167.0 million, and -$173.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 488.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 76.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -85.46 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 178.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 90.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -172.00 Mn |
| Dec 31, 2024 | -172.00 Mn |
| Dec 31, 2023 | -167.00 Mn |
| Dec 31, 2023 | -167.00 Mn |
| Dec 31, 2022 | -173.00 Mn |
| Dec 31, 2022 | -173.00 Mn |
| Dec 31, 2021 | -175.00 Mn |
| Dec 31, 2021 | -175.00 Mn |
| Dec 31, 2020 | -188.00 Mn |
| Dec 31, 2020 | -188.00 Mn |
| Dec 31, 2019 | -408.00 Mn |
| Dec 31, 2019 | -408.00 Mn |
| Dec 31, 2018 | -347.00 Mn |
| Dec 31, 2018 | -347.00 Mn |
| Dec 31, 2017 | -376.00 Mn |
| Dec 31, 2017 | -376.00 Mn |
| Dec 31, 2016 | -392.00 Mn |
| Dec 31, 2016 | -392.00 Mn |
| Dec 31, 2015 | -358.00 Mn |
| Dec 31, 2015 | -358.00 Mn |